PCP
FBT icon

Perimeter Capital Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Perimeter Capital Partners’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-4,914
Closed -$405K – 113
2014
Q2 		$405K Buy
4,914
+24
+0.5% +$1.83K 0.21% 168
2014
Q1 		$375K Buy
+4,890
New +$382K 0.19% 169

Other funds holding FBT

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return

Perimeter Capital Partners's FBT Position: Q3 2014 in Review

Perimeter Capital Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2014, closing a stake of 4,914 shares — an estimated $405K sold.

Perimeter Capital Partners first reported a position in FBT in Q1 2014 and held it in 2 quarters. The position peaked at $405K in Q2 2014. 98 funds tracked by Wall St. Rank hold FBT as of Q3 2014.

  • Perimeter Capital Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q3 2014 after selling out during the quarter.
  • Perimeter Capital Partners sold 4,914 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2014, an estimated $405K.
  • Perimeter Capital Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2014 and held it in 2 quarters.
  • Perimeter Capital Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $405K in Q2 2014.
  • 98 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2014.

Based on Perimeter Capital Partners's 13F filing for Q3 2014, filed 10 Nov 2014.